
About NanoCytomics
NanoCytomics is a Technology company based in Evanston (United States) founded in 2011. Imaging-based diagnostic devices for cancer are developed. It operates in the Technology and Healthcare sectors. NanoCytomics offers products and services including PWS Platform, Nanocytology, and Field Effect Technology. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is NanoCytomics LLC. Its competitors include Scholar Rock, Ionpath and Fluxion Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
NanoCytomics was founded in 2011 in Evanston, United States, within the biotechnology sector. Diagnostic devices utilizing imaging technologies are developed to detect cancer through nanoscale analysis of cellular structures. An exclusive license from Northwestern University is maintained for patents on partial wave spectroscopic microscopy, which enables optical sensing of cell functions and abnormalities. Operations center on advancing biophotonics for early cancer identification.
- Headquarters Evanston, United States
- SectorsTechnologyHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website nano-cytomics.com
- Social LinkedIn
- Legal Name Nanocytomics Llc
- Latest Funding Round$3.47M (USD), Grant
Sep 2012
- InvestorsHHS
& 1 more
Products & Services of NanoCytomics
NanoCytomics offers a comprehensive portfolio of products and services, including PWS Platform, Nanocytology, and Field Effect Technology.
Provides non-invasive cancer risk assessment for early detection
Enables accurate, low-cost analysis of cancer risks in patients
Offers fingerprint-based risk discovery for cancer screening
Funding Insights of NanoCytomics
- Total Rounds 3
- Last Round Grant β $3.47M
- First Round $149,970
(May 2012)
- Investors Count 2
All 3 funding rounds of NanoCytomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2012 | $3.47M | Grant | β | β | |
| Jul 2012 | $149,970 | Grant | β | β | |
| May 2012 | $149,970 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in NanoCytomics
NanoCytomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for NanoCytomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NanoCytomics
3 dated milestones of NanoCytomics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded NanoCytomics is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Grant, of $3.5M.
Competitors of NanoCytomics
NanoCytomics has 3 listed competitors in our database, 3 of them funded. They include Scholar Rock, Ionpath and Fluxion Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| scholarrock.com | 2012 | Cambridge, United States | $103.3M | 150 | Antibody-based drugs for primary myopathies are developed and targeted. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | Microfluidics-based tools for cellular analysis are provided. |
Detailed competitors of NanoCytomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
3 companies that operate in the same segment as NanoCytomics (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 34.92 M | 9,630 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NanoCytomics
NanoCytomics was founded in 2011 and raised its 1st funding round 1 year after it was founded.
NanoCytomics is headquartered in Evanston, United States. It is registered at Evanston, Illinois, United States.
NanoCytomics was founded in 2011 in Evanston, United States, within the biotechnology sector. Diagnostic devices utilizing imaging technologies are developed to detect cancer through nanoscale analysis of cellular structures. An exclusive license from Northwestern University is maintained for patents on partial wave spectroscopic microscopy, which enables optical sensing of cell functions and abnormalities. Operations center on advancing biophotonics for early cancer identification.
NanoCytomics's top competitors include Scholar Rock, Ionpath and Fluxion Biosciences.
NanoCytomics offers PWS Platform, Nanocytology, and Field Effect Technology.
NanoCytomics has 2 investors. Key investors include HHS, and National Science Foundation.
NanoCytomics operates through Nanocytomics Llc.